"Dorzopt" (maka kulu): alakaʻi, hōʻike manaʻo, analogs

Glaucoma - Heʻano nui pūʻulu o ka maka maʻi, a i wehewehe aku ma ka papa'āweʻaweʻa kemika a paʻa mahuahua ma intraocular puʻe me mahope? Acaeoey mā, optic atrophy a me ka emi ana ma ka pilikia makapō acuity.

No ka iapaau ana o ka maʻi ka hoʻohana 'ana i kekahi mau ai'. Ka loa, he pono ole ka lapaʻauʻia ka "Dorzopt" (maka kulu). Consumer nāʻana, kuhikuhi ma ka hana o keia lapaau, e e kūkā mai ma lalo nei.

Hāʻawe a me ka haku mele 'ana

He aha ka waiwai he i ka lāʻau "Dorzopt" (maka kulu)? Kaʻeleu ke keʻena o ka lāʻau mea dorzolamide (like hydrochloride). I ka medicament loaʻa nā kēia kākoʻo 'ona: Benzalkonium koloriside, gietelloza, mannitol, paʻakai hydroxide, citricʻakika monohydrate, maloko wai.

Nānā akula au i huahana hua mai la i ka polyethylene hue me 5 ml dropper kīʻamo.

pharmacodynamics

He aha nā maka kulu "Dorzopt"? Alakaʻi ai ia mau moʻolelo i kēia mea paahana mea he kūloko carbonic anhydrase inhibitor. Ua loaʻa he e kaumaha ana ia ma luna o ka intraocular loli secretion a inhibits ke kahua o ka hydrogen kalepona a me ka hoʻonāwaliwali i ka wai o ka hoolilo a me ka paʻakai.

Kēia lāʻau 'Aʻole ole i miosis a me ka po, ka makapō, e like me ka spasm o ka noho.

Pharmacokinetics

ina paha i ka lāʻau o ke kemu, "Dorzopt" (maka kulu)? Omo o ka lāʻau i wahi ma ka cornea, a ma ka lala a me ka sclera. lāʻau systemic omo holo 'awelika i loa haʻahaʻa.

Noho i loko o ke koko, i ka lāʻauʻeleu 'Oponopono hoʻomaka koke komo i loko oʻulaʻula koko keena me ka maʻiʻo kiʻekiʻe o carbonic anhydrase 2.

Palapala me ka wai koko nā polokina ia lŘlŘ ka 33%. Ka lāʻau 'ua hoohuliia i N-dezetilirovanny metabolite, i mea ole loa hana ku e carbonic anhydrase 2, akā, ua hiki mai o ka paleʻana i kekahi carbonic anhydrase.

Hooloihi ae i hoʻohana ana i ka lāʻau 'hiki aku ai i kona hoʻomāhuahua i loko o erythrocytes.

E hōʻike 'ia ka lapaʻauʻia ma nā puʻupaʻa. Lākou wehe 'ana he 2 hoʻopau pae: hoʻokēʻai a me ka lohi. Ka hope ua kena ae la ma o ka holo kala ana o ka hana ke keʻena o ka ula koko keena.

hapa-ola manawa o ma kahi o 4 mahina.

hoike

I ka prescribers "Dorzopt"? Eye kulu i loa mana i loko o ka iapaau ana o ke kiekie intraocular puʻe i loko o ka poe me ka ocular hypertension a hamama-pseudoexfoliative glaucoma (me kiʻekiʻe).

Contraindications

Ma ka hoopii, e hiki ole hoʻohana i ka lāʻau "Dorzopt"? Eye kulu mea i hoakaka ia no:

• hyperchloraemic acidosis;
• Hypersensitivity i ka constituent hehee wale;
• loa hakuʻala kāna hana;
• like me ka nīnūnē;
• i loko o ka lactation au.

Me ka lōʻihi mālama nui e e hoʻohana i kēia mea paahana.

• mimikō;
• nā mea maʻi me ka hepatic hoʻopilikia;
• poe me ka uuku nuʻa o ka cornea endothelium keena o ka maka (o ka pahiki kiʻekiʻe o corneal edema).

Dosing

Hāʻawi aku hoi i manao i mea paahana no ka iapaau ana o ka maka mai i wale i ka puali ololi e hoʻomalu ma hope o akahele ninaninau o ka hoʻomanawanui. E kanu hoʻomanaʻo desirably kekahi kulu i loko o ka conjunctival sac o ekolu manawa no ka lā.

Me ka hui malu pu ana o ka ai 'me ka Hoʻokolohua-blockers topical lāʻau e hoʻohana i kekahi kulu palua kela la i keia.

Inā ocular maʻi Inc kikowaena mau ophthalmic hope, i ka wā mawaena ma waena o lākou instillation pono e ma ka liʻiliʻi umi minuke.

ʻaoʻao waiwai

Inā 'oe ke hoʻohana maka kulu "Dorzopt" Na kēia i nā reactions e hoʻomōhala i nā mea maʻi:

• Maneo a kuni ka waiʻona ma loko o ka maka, conjunctivitis, paresthesia, lihilihi edema, haehae, blepharitis, hoʻopōʻino mōakaaka o ka hihiʻo, a me ka photophobia superficial punctate keratitis.
• Loa kākaʻikahi ku noi o ka lāʻau i: iridocyclitis, mahuahua ka mānoanoa o ka cornea, allergy, hypotension maka a me ka retinal poe ma hope o antiglaukomatoznyh hana.

Systemicʻaoʻao 'ole:

• aloha o ka nausea,ʻawaʻawa ho'āʻoʻana i loko o ka waha, nefrourolitiaza kūpono 'ana, ka luhi, migraine, malignant exudative erythema multiforme, ʻawahia epidermal necrolysis, anaemia aplastic, ili poʻe noʻonoʻoʻole a me ka agranulocytosis.

hihia o ka overdose

He aha symptoms ka wā hoʻohana 'ana i "Dorzopt" kiʻekiʻe nā māhele o ka waiʻona i hoʻomaka ai? Eyedrops, analogs i mea hōʻike ia ma lalo nei, ke haawi:

• acidosis ulu ana;
• ka hoʻohuikau 'ana o ka wai a me ka electrolyte koena;
• CNSʻaoʻao waiwai.

No ka iapaau ana o ia mau rula e hauhoa symptomatically, pu ma ka hooponopono ana o ka nui o nā electrolytes a me ke koko pH.

lāʻau hana kūleʻa

• I ka hui me ka lāʻau antiglaucoma konohiki (Hoʻokolohua-blockers, "dipivefrin", "pilocarpine", "Carbachol") amplifies kona kanawai.
• Me ka "acetazolamide" maoli i ka pilikia o systemicʻaoʻao loa.
• Me ka nui dosages o acetylsalicylicʻakika maoli ka kaʻawahia o ka lāʻau.

kekahi koi

Ka hoʻohana a multidose ehiku huewai i kāhea i ke kūpono 'ana o ka mea koʻohune keratitis. Kēia mea ma muli o ke inadvertent mea hoʻohaumia o ko lākou mau Contents.

Ma lapaʻau "Dorzoptom" E i hoʻohana nā aniani kaulona like benzalkonium koloriside hiki eʻawahia, a i ae hookaawale i na maka.

Analogs a me ka lāʻau kumukuai

E puku i ka noonoo lāʻau a hiki i ka maka hiki e ma ka mea e like me "Trusopt" a me ka "Floksal". Price o ka lāʻau ma kahi o ka 350 rubles.

consumer hōʻike manaʻo

Eia naʻe, consumer hōʻike manaʻo e pili ana i ka lāʻau "Dorzopt" mea pohihihi keia. Mawaena o ka papa kuhikuhiE pono o kēia lāʻau 'palapala aie e like me loaʻa nui a me ka laulā. Naʻe, kekahi nā mea kūʻai mai i mea e hopohopo nei, kūloko a me ka systemic adverse reactions e hana ana i kanaka me na kulu. Ma keia manao, poe akamai i ke waiho aku i ka hoʻohana 'ana i ka lāʻau ma lalo o ka inoa "Dorzopt hoʻohui".

Eyedrops haiia ae maluna, loaʻa ia i nā waiwai, e like me timolol. Ua kākoʻo i ka nōkahea o intraocular loli.